References
- . Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163(4):487–494
- . Centers for Disease Control and Prevention. Influenza: the disease. http://www.cdc.gov/flu/about/disease/index.htm. Accessed July 28, 2008
- . National Institute of Allergy and Infectious Diseases of the National Institutes of Health. Common cold. http://www3.niaid.nih.gov/healthscience/healthtopics/colds/overview.htm. Accessed July 30, 2008
- . Fendrick AM. Viral respiratory infections due to rhinoviruses: current knowledge, new developments. Am J Ther. 2003;10(3):193–202
- . Cross ML, Ganner A, Teilab D, Fray LM. Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol. 2004;42(2):173–190
- . De Vecchi E, Drago L. Lactobacillus sporogenes or bacillus coagulans: misidentification or mislabeling? Int J Probiotics and Prebiotics. 2006;1:3–10
- . Yasui H, Kiyoshima J, Hori T. Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol. 2004;11(4):675–679
- . Hatakka K, Savilahti E, Pönkä A,. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ. 2001;322(7298):1–5
- . Breed RS, Murray EGD, Smith NR,. Bergey's Manual of Determinative Bacteriology. 7th ed. Baltimore, MD: The Williams and Wilkins Co; 1957
- . Ara K, Meguro S, Hase T,. Effect of spore-bearing lactic acid-forming bacteria (Bacillus coagulans SANK 70258) administration on the intestinal environment, defection frequency, fecal characteristics and dermal characteristics in humans and rats. Microb Ecol Health Dis. 2002;14:4–13
- . Perdigón G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol. 2001;2(1):27–42
- . Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115(1):178–181
- . Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr. 2001;73( 2 suppl):465S-–470S
- . Winkler P, de Vrese M, Laue Ch, Schrezenmeir J. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int J Clin Pharmacol Ther. 2005;43(7):318–326
- . Turchet P, Laurenzano M, Auboiron S, Antoine JM. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. J Nutr Health Aging. 2003;7(2):75–77
- . de Vrese M, Winkler P, Rautenberg P,. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine. 2006;24(44–46):6670–6674
- . Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol. 2007;23(6):679–692
- . Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 2000;130( 2 suppl):396S-–402S
- . Tuomola E, Crittenden R, Playne M, Isolauri E, Salminen S. Quality assurance criteria for probiotic bacteria. Am J Clin Nutr. 2001;73( 2 suppl):393S–398S
- . Marco ML, Pavan S, Kleerebezem M. Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol. 2006;17(2):204–210